Strados Labs

Strados Labs is a Philadelphia-based digital health company founded in 2018, focused on transforming respiratory monitoring through its FDA 510(k)-cleared and CE-marked RESP® Platform. The company's core technology is a discreet, wearable biosensor that continuously captures high-fidelity lung sounds and physiological data, which is then analyzed in the cloud for clinical and research applications. Strados primarily serves the life sciences industry by providing digital endpoints for respiratory clinical trials and is expanding into remote patient monitoring, with its technology validated and deployed across numerous global clinical sites.

The RESP® Platform is an end-to-end wearable respiratory monitoring system. It consists of a wireless, wearable stethoscope biosensor (and a watch-based device) that continuously captures lung sounds (cough, wheeze, crackles) and physiological data. Data is transmitted to a HIPAA-compliant cloud where proprietary algorithms provide automated or human-overread analysis and reporting.

Strados competes in the digital respiratory monitoring space with companies developing smartphone-based cough counters, wearable patches with acoustic sensors, and connected spirometers. Its differentiation lies in the medical-grade, high-fidelity capture of full-spectrum lung sounds (beyond just cough), its FDA clearance, and its focus on the clinical research B2B market with a full platform solution.